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Abstract
Background: Overwhelming activation of granulocytes and monocytes is central to
inflammatory responses during sepsis. Granulocyte and monocyte adsorptive apheresis
(GMA) is an extracorporeal leukocyte apheresis device filled with cellulose acetate
beads and selectively adsorbs granulocytes and monocytes from the peripheral blood.
Methods: In this study, septic rats received the GMA treatment for 2 h at 18 h after
cecal ligation and puncture.
Results: GMA selectively adsorbed activated neutrophils and monocytes from the
peripheral blood, reduced serum inflammatory cytokine expression, and seemed to
improve organ injuries and animal survival. GMA potentially reduced lung injury by
alleviating the infiltration of inflammatory cells and the secretion of cytokines.
Conclusions: This study showed that selective granulocyte and monocyte adsorption
with cellulose acetate beads might ameliorate cecal ligation and puncture (CLP)-induced
sepsis and improve survival and organ function.
Keywords: Sepsis, Inflammation, Granulocyte, Monocyte, Adsorption, Cellulose acetate
Background
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host
response to infection [1]. Despite progress in antibiotics and critical care therapy,
sepsis remains the most common cause of death in the intensive care unit [2]. Sepsis
affects the immune system by directly altering the lifespan, production, and function of
the effector cells responsible for homeostasis [3]. Additionally, innate and adaptive im-
mune system cells play a critical role in the host response to sepsis [4]. Leukocytes,
such as granulocytes and monocytes, are central to the inflammatory responses to
infection, which involves phagocytosis, the production and release of reactive oxygen
species and cytokines, and the adhesion to and infiltration into the tissue [3–6].
However, overwhelming activation of granulocytes and monocytes can contribute to
significant cell and tissue damage [7].
Different therapeutic approaches to prevent such damage caused by granulocytes
and monocytes have been developed, such as inhibiting granulocyte and macrophage
extravasation and adhesion, blocking the actions of their proinflammatory cytokines,
and attenuating reactive oxygen species [8, 9]. However, these treatments have shown
little or modest effects on disease process when tested clinically [8, 9]. Because
activated leukocytes are central to the pathogenesis and progression of sepsis, an
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alternative approach to limit the deleterious clinical effect of activated leukocytes may
be selective adsorption of excess and activated leukocytes, which may result in
immunomodulation.
Granulocyte and monocyte adsorptive apheresis (GMA) is an extracorporeal
leukocyte apheresis device filled with cellulose acetate beads and selectively adsorbs
granulocytes and monocytes from the peripheral blood [10]. Cellulose acetate beads
have been used to treat patients with various autoimmune diseases such as rheumatoid
arthritis [11, 12], ulcerative colitis [10, 13], and Crohn’s disease [14]. The mechanism of
selective adsorption is thought to be mediated by the interaction of the complement re-
ceptor and Fc receptor on granulocytes and monocytes, whereas complement factors
and immunoglobulins adhere to the surface of cellulose acetate beads via ligand-
receptor interactions [6, 15]. Typically, the beads adsorb approximately 65% of granulo-
cytes, 55% of monocytes, and 2% of lymphocytes from the blood [16]. However, GMA
has not yet been clinically applied to treat sepsis. Only one ex vivo animal study
showed that selective adsorption regulated phagocytic activity and adhesiveness of
granulocytes in sepsis [17] and thus, its effects remain unclear. In this study, we estab-
lished an in vivo miniature GMA for rats to evaluate the therapeutic effects in sepsis.
Methods
Cecal ligation and puncture (CLP)
Adult male Sprague–Dawley rats (450–550 g) were used in this study. All surgical pro-
cedures were carried out under general anesthesia induced by 4% chloral hydrate
(0.9 mL/100 g intraperitoneally). The cecum was identified and ligated at 25% length of
the cecum. A double puncture of the cecal wall was performed with a 20-gauge needle,
and the cecum was gently squeezed to ensure that a small amount of feces was ex-
truded onto the surface of the bowel [18]. For sham CLP rats, the cecum was minimally
handled without ligation and puncture.
Experimental protocol for GMA use in rats
Eighteen hours after CLP, the animals were re-anesthetized with chloral hydrate. The
left carotid artery and right external jugular vein were isolated by dissection and cannu-
lated with 0.97-mm polyethylene-50 tubing (BD Biosciences, Franklin Lakes, NJ, USA)
for implementation of extracorporeal circulation. The GMA consisted of a mini-
column filled with 10 g cellulose acetate beads (cellulose acetate beads; JIMRO, Gunma,
Japan), mini-pumps (VWR, West Chester, PA, USA), and tubing lines (Fig. 1).
Eighteen hours after CLP, the animals were randomly assigned to receive either GMA
or sham GMA treatment for 2 h. Extracorporeal circulation was driven by a mini-
pump from the left carotid artery to the right external jugular vein at a blood flow rate
of 1.0 mL/min. A volume of 62.5 U/mL of heparin was used to prevent coagulation in
this circuit. In the GMA group, the extracorporeal circulation passed through a mini-
column filled with cellulose acetate beads. In the sham GMA group, the extracorporeal
circulation was set up in the same manner but without beads. In the control group, all
rats underwent the sham CLP procedure without extracorporeal circulation.
Blood samples were collected for cell classification and counting at 0, 1, and 2 h dur-
ing extracorporeal circulation. Neutrophil and monocyte numbers were determined
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from stained cytospins by the Wright-Giemsa staining (Sigma-Aldrich, St. Louis, MO,
USA). Survival time was assessed for up to 7 days.
Scanning electron microscopy (SEM) and immunofluorescence (IF) images
After GMA treatment, the cellulose acetate beads were collected for observing the cell
adherence to them using SEM and characterizing the adherent cells using IF micros-
copy. The beads were fixed in 1% OsO4, dehydrated in alcohol gradients, and then im-
aged using QUANTA 200 SEM (FEI, Hillsboro, OR, USA) as described previously [19].
For IF images, the beads were stained with DAPI (4′,6-diamidino-2-phenylindole; BD
Biosciences) and CD11b (R&D Systems, Minneapolis, MN, USA) as described previ-
ously [19] and then observed under a confocal laser scanning microscope (Leica Micro-
systems, Heidelberg, Germany).
Flow cytometric analysis
Blood samples were collected, and erythrocytes were lysed (Erythrocyte Lysis Kit; R&D
Systems). Splenocytes and pulmonary cells were isolated as previously described [20, 21].
Briefly, spleens were harvested and homogenized by smashing with the plunger
from a syringe. The dispersed spleens were passed through a 70-mm nylon mesh,
and erythrocytes were lysed. The lungs were harvested, finely minced, and digested
Fig. 1 Schematic drawing of granulocyte and monocyte adsorptive apheresis (GMA) for septic rats
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in 10 mL collagenase type II (2 mg/mL; Sigma-Aldrich), and then, erythrocytes
were lysed.
Fluorochrome-labeled antibodies CD4, CD8, CD45, CD11b, HIS36, and HIS48
(eBioscience, San Diego, CA, USA) were used for surface staining according to the
manufacturer’s instructions. After staining, the cells were analyzed by flow cytometry
(BD Biosciences).
Analysis of bronchoalveolar lavage fluid (BALF)
BALF was obtained by lavaging the left lung once with 2 mL PBS and three times with
4 mL PBS. Total cells were counted under optical microscopes. Total protein in the
first BALF was measured using a bicinchoninic acid kit (Sigma-Aldrich). The levels of
inflammatory-associated cytokines in the first BALF were measured by enzyme-linked
immunosorbent assay (ELISA).
ELISA
The concentrations of TNF-α, IL-1β, IL-6, and IL-10 were measured using ELISA kits
from eBioscience (eBioscience, San Diego, CA, USA).
Histopathologic analysis of the lung and liver
Lung sections were stained with hematoxylin and eosin. All lung fields at ×200 magnifi-
cation were examined for each sample. Assessment of histological lung injury was per-
formed as follows: 1 = normal; 2 = focal (<50% lung section) interstitial congestion and
inflammatory cell infiltration; 3 = diffuse (>50% lung section) interstitial congestion and
inflammatory cell infiltration; 4 = focal (<50% lung section) consolidation and inflam-
matory cell infiltration; 5 = diffuse (>50% lung section) consolidation and inflammatory
cell infiltration [22].
Liver sections were stained with hematoxylin and eosin. Hepatic injury scores were
measured based on liver morphological criteria [23]: spotty necrosis, capsular inflam-
mation, portal inflammation, ballooning degeneration, and steatosis. The scoring
system was as follows: 0 = none (no change), 1 = mild changes, 2 = moderate
changes, 3 = severe changes.
Measurements of liver functions
Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were
measured with an automated chemical analyzer (Vitros-950, Johnson & Johnson, New
Brunswick, NJ, USA).
Statistical analysis
All numerical data are expressed as mean ± SEM. Student’s t tests were used for com-
parisons between two groups. Multiple group comparisons were performed by one-way
ANOVA followed by a post hoc Tukey’s test to compare each group. Survival analysis
was performed using the Kaplan-Meier method and log-rank test. All statistical ana-
lyses were performed with GraphPad Prism software (GraphPad Software, La Jolla, CA,
USA), and a 2-sided p < 0.05 was considered significant.
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Results
GMA selectively adsorbed peripheral blood leukocytes and ameliorated CLP-induced sepsis
After 2-h GMA treatment, the number of peripheral leukocytes significantly decreased
(p < 0.001, 0-h GMA vs. 2-h GMA, Fig. 2a), while there was no change in the sham
GMA group (p > 0.05, 0-h sham GMA vs. 2-h sham GMA, Fig. 2a). Particularly, this
treatment resulted in the removal of neutrophils and monocytes from the peripheral
blood (both p < 0.001, 0-h GMA vs. 2-h GMA, Fig. 2a). SEM and IF images confirmed
the adsorption neutrophils and monocytes onto the surface of the beads (Fig. 2b, c).
Mac-1 (CD11b/CD18) is expressed predominantly on neutrophils and monocytes/mac-
rophages; when these cells are activated, Mac-1 expression increases [24]. Figure 2d, e
shows the change in CD11b expression in peripheral leukocytes before and after GMA
treatment. The expression of CD11b was significantly downregulated after GMA treat-
ment compared with that after sham GMA treatment (p < 0.001, GMA vs. sham GMA,
Fig. 2d, e). These data demonstrate that GMA might selectively adsorb activated neu-
trophils and monocytes in the peripheral blood.
We next investigated whether GMA treatment can ameliorate sepsis. First, we found
that GMA improved the survival of rats with CLP-induced sepsis. The data showed
that the 7-day survival rate of the GMA group was 46.7%, while the rate reduced to
Fig. 2 Granulocyte and monocyte adsorptive apheresis (GMA) selectively adsorbed activated neutrophils
and monocytes of peripheral blood in septic rats. a White blood cells were counted at 0, 1, and 2 h during
the GMA treatment; neutrophil and monocyte numbers were determined from stained cytospins by the
Wright-Giemsa staining (n = 5–6 per group). b Scanning electron microscopy images of the cellulose acetate
beads after GMA treatment. c Leukocytes were adsorbed onto the cellulose acetate beads after GMA treatment
and were stained with DAPI (blue) and CD11b (red) at ×200 ×Z 1.0 magnification. d, e Peripheral blood
neutrophils were collected at 0 and 2 h during GMA treatment. The mean fluorescence intensity of
CD11b was analyzed by flow cytometry (n = 5–6 per group). *p < 0.05, **p < 0.01, ***p < 0.001. Data are
expressed as mean ± SEM. WBC white blood cell, DAPI 4′,6-diamidino-2-phenylindole
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73.3% in the sham GMA group (p = 0.047, GMA vs. sham GMA, Fig. 3a). Leukocytes
release cytokines during sepsis. We next measured the levels of inflammatory-
associated cytokines including TNF-α, IL-1β, IL-6, and IL-10 in the serum. At 48 h
after CLP, the levels of these cytokines increased significantly in the sham GMA group
compared with that in the control group (p < 0.001, Fig. 3b). GMA treatment decreased
the levels of TNF-α (p < 0.05), IL-1β (p < 0.01), IL-6 (p < 0.05), and IL-10 (p < 0.01)
compared with the subjects in the sham GMA treatment (Fig. 3b). Sepsis may result in
multiple organ dysfunctions; thus, we assessed liver and lung injury. At 48 h after CLP,
the levels of serum ALT and AST were elevated in the sham GMA group compared
with the subjects in the control group (p < 0.05, sham GMA vs. control, Fig. 3c). These
values decreased significantly in GMA-treated rats (p < 0.05, GMA vs. sham GMA,
Fig. 3c). The pathology of the liver, which includes necrosis, inflammation, degener-
ation, and steatosis, in the sham GMA group showed much more severe injuries com-
pared with that in the control group (Fig. 3d). However, the injuries were ameliorated
after GMA treatment (Fig. 3d). Furthermore, injury scores in the liver (p < 0.05, sham
GMA vs. GMA, Fig. 3e) confirmed the protective effects of GMA. The pathology of
interstitial congestion and inflammatory cell infiltration in the lung indicated much
more severe injuries in the sham GMA group than those in the control group (Fig. 3f ).
The injuries were ameliorated after GMA treatment (Fig. 3f ). Similarly, after GMA
treatment, the injury scores of the lung also decreased (p < 0.05, GMA vs. sham GMA;
Fig. 3g). These data suggest that GMA treatment might prolong survival time, reduce
Fig. 3 Granulocyte and monocyte adsorptive apheresis (GMA) ameliorated CLP-induced sepsis. a Survival
was plotted for a 7-day period (n = 22–25 per group). b Serum inflammatory-associated cytokines were
measured by ELISA at 48 h after CLP (n = 6–7 per group). c Serum ALT and AST were quantified at 48 h after
CLP (n = 6–7 per group). d, f Representative photomicrographs of liver sections stained with hematoxylin and
eosin (HE) and examined at ×100 magnification and of kidney sections stained with HE and examined at ×200
magnification. e, g Histopathologic mean liver and lung injury were scored at 48 h after CLP (n = 6 per group;
at least 10 fields were reviewed for each slide). *p < 0.05, **p < 0.01. Data are expressed as mean ± SEM. CLP
cecal ligation and puncture, ALT alanine aminotransferase, AST aspartate aminotransferase, ELISA enzyme-linked
immunosorbent assay
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inflammation, and ameliorate liver and lung injuries of CLP-induced sepsis compared
with the sham GMA treatment.
GMA alleviated pulmonary inflammation
Inflammatory cells and cytokines lead to lung injury in sepsis; the lung is one of the
first organs to be affected in this pathophysiological process [25]. Neutrophils and
monocytes in the peripheral blood were adsorbed during GMA treatment. Thus, we
analyzed whether this treatment could further reduce the infiltration of leukocytes in
the lung using flow cytometry. The infiltration of neutrophils and macrophages in the
lung of the GMA group was significantly reduced compared with that in the sham
GMA group (both p < 0.05, Fig. 4a, b) at 48 h after CLP. We also counted the total cells
in the BALF of different groups and found that the total BALF cell count in the sham
GMA group was much higher than that in the GMA group (p < 0.05, Fig. 4c). We
determined the concentration of total protein in the BALF to assess pulmonary vascu-
lar leakage. At 48 h after CLP, total protein levels in the BALF were elevated in the
sham GMA group compared with the subject in the control group (p < 0.05, sham
GMA vs. control, Fig. 4d), while total protein decreased significantly after GMA treatment
(p < 0.05, GMA vs. sham GMA, Fig. 4d). To further evaluate pulmonary inflammation in
septic rats, the levels of inflammatory-associated cytokines (TNF-α, IL-1β, IL-6, and IL-
10) were measured in the BALF samples. We found that the levels of these cytokines were
Fig. 4 Granulocyte and monocyte adsorptive apheresis (GMA) alleviated inflammation in the lungs. a The
levels of neutrophils and macrophages in the lung were analyzed by flow cytometry at 48 h after CLP
(n = 7–9 per group). b Gating strategy for identifying neutrophils and macrophages in the lung. Granulocyte
marker [HIS48] and CD45 double-positive cells were defined as neutrophils. Macrophage marker [HIS36] and
CD45 double-positive cells were defined as macrophages of rats. c Total cell counts in BALF at 48 h after
CLP (n = 7–9 per group). d Total protein in BALF at 48 h after CLP (n = 7–9 per group). e Inflammatory-
associated cytokines in the BALF were measured by ELISA at 48 h after CLP (n = 7–9 per group). *p < 0.05,
**p < 0.01. Data are expressed as mean ± SEM. CLP cecal ligation and puncture, BALF broncho alveolar lavage
fluid, ELISA enzyme-linked immunosorbent assay
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increased significantly in the sham GMA group compared with those in the control group
(all p < 0.001, Fig. 4e). GMA treatment decreased the levels of these cytokines compared
with the sham GMA treatment at 48 h after CLP (all p < 0.05, Fig. 4e). Taken together,
these data suggest that the GMA might reduce lung injury by alleviating inflammatory
cells and cytokines in the lung compared with the sham GMA treatment.
No change in the level of T lymphocytes after GMA
To assess the adaptive immune response, circulating and splenic levels of CD4+ helper
T cells and CD8+ cytotoxic T cells were measured by flow cytometry at 72 h after CLP.
However, there was no significant difference in the peripheral blood or spleen between
the GMA group and sham GMA group (all p > 0.05, Fig. 5). Thus, 2-h GMA treatment
had no effect on the levels of T lymphocytes in the current rat model.
Discussion
In the present study, we established a granulocyte and monocyte adsorptive apheresis
for septic rats. The number of granulocytes and monocytes were decreased after pass-
ing through the cellulose acetate beads. Most adsorbed leukocytes were granulocytes.
According to studies on ulcerative colitis, the reduction in granulocyte count peaked at
15 min after GMA treatment but did not decrease to below the normal range [17]. We
also found that there was no significant decrease in the number of neutrophils after 4-h/
6-h GMA treatment (data not shown). It is thought that neutrophils are mobilized from
the marginal pools, including the bone marrow [26]. Some studies have shown reduced
peripheral neutrophils during the GMA procedure, mainly old and activated neutrophils
which were CD10+ [27]. The maximum mobilization of CD10− neutrophils was observed
Fig. 5 Granulocyte and monocyte adsorptive apheresis (GMA) had no effect on the levels of T lymphocytes
in septic rats. Circulating and splenic levels of CD4+ helper T cells and CD8+ cytotoxic T cells were analyzed
by flow cytometry at 72 h after CLP (n = 7–9 per group). CLP cecal ligation and puncture, ns no significance
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within 30 min of GMA. CD10− neutrophils are immature naïve neutrophils from the bone
marrow and thought to not be proinflammatory [26].
It is thought that cellulose acetate beads can adsorb not only excess leukocytes but
also activated leukocytes. Mac-1 (CD11b/CD18), the major subtype of integrins, is re-
sponsible for the firm adhesion of neutrophils to the endothelium. Once neutrophils
are activated, the shape of these cells changed and the amount of Mac-1 increases,
resulting in enhanced adhesion to the endothelium and transmigration and infiltration
of these neutrophils [28]. In our experimental system, expression of CD11b on periph-
eral leukocytes was significantly downregulated after GMA treatment. Hara et al. also
reported that the number of CD11b+ cells markedly decreased in an ex vivo study on
septic models [17]. However, in inflammatory bowel disease and rheumatoid arthritis
patients who received GMA treatment [24, 29], CD11b was upregulated, while L-selectin
was downregulated. Upregulation of Mac-1 is not sufficient to promote leukocyte traffick-
ing in these diseases because the reduction in L-selectin and the initial step in leukocyte-
endothelial cell interaction is impaired; thus, the overall adhesiveness of granulocytes was
reduced [24, 29].
Sepsis may result in multiple organ dysfunctions, such as injury of the lung, kidney,
and liver. The septic response may be accelerated following continued activation of
neutrophils and macrophages/monocytes [30], which migrate to damaged sites and
induce cytokine release. In our study, after the adsorption of activated leukocytes, the
levels of serum inflammatory-associated cytokines (TNF-α, IL-1β, IL-6, and IL-10)
decreased and organ injuries were ameliorated. In some experimental and clinical
studies have reported that the reduction or clearance of inflammatory mediators by
various forms of blood purification such as high-volume hemofiltration, high-cutoff
hemofiltration, and hemoadsorption in sepsis could improve organ functions [19, 31–34].
In another group, Zhiyong Peng et al. found that the CytoSorb beads could modulate
leukocyte trafficking in a septic rat model and in an ex vivo human sepsis study [19, 35].
Those beads significantly removed plasma cytokines and chemokines and decreased
BALF-to-blood chemokine ratios, resulting in decreased leukocytes recruitment into the
lung. So, the modulation of chemokine gradients is important for leukocyte trafficking to
different compartments during sepsis.
During bacterial infections, extensive interactions occur between antigen-presenting
cells and lymphocytes, which are key effector cells in the adaptive immune response
[30]. Sepsis not only causes hyper-inflammation but also leads to an anti-inflammatory
or immunosuppressive phase. In this phase, the adaptive immune system is dysfunc-
tion, including immune cell depletion (especially T cells), compromised T cell functions
and T cell exhaustion [36, 37]. To assess the adaptive immune response, we measured
circulating and splenic levels of CD4+ helper T cells and CD8+ cytotoxic T cells at 72 h
after CLP. However, the data showed that the 2-h GMA treatment had no effect on T
lymphocyte levels.
This study had some limitations. First, our results for leukocyte surface marker
(CD11b) expression reflected only the remaining circulating cells and not those
adsorbed onto the beads. Moreover, L-selectin is involved in the initial step of the
leukocyte-endothelial cell interaction. The levels of L-selectin need to be measured,
which is important for evaluating the adhesiveness of granulocytes. Second, we were
unable to determine whether this cell adsorption affected the adaptive immune
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response for not evaluating the function of lymphocytes. Third, further studies on
different therapeutic doses and different onset times after CLP are needed.
Conclusions
In summary, this is the first study to show that selective granulocyte and monocyte
adsorption with cellulose acetate beads might ameliorate CLP-induced sepsis and im-
prove survival and organ function in vivo compared with the sham GMA treatment.
Additional studies are needed to further investigate these results. Our results may be
used in the development of new therapies for patients with sepsis.
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